https://www.thebodypro.com/category/prep-hiv-pre-exposure-prophylasxis/tag/interviews

The Latest

doctor talking to unrecognizable patient

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.

By Terri Wilder, M.S.W.
Juan Berenguer, M.D., Ph.D. and Antonio Urbina, M.D.

Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM

Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.

By Terri Wilder, M.S.W. and Myles Helfand
Annette Gaudino and Bryn Gay

With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues

The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.

By Terri Wilder, M.S.W.
injectable

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.

By Terri Wilder, M.S.W.
Lynne Mofenson

After Years of Decline, Perinatal HIV Transmission Has Hit a Plateau. Why?

This researcher has some ideas about what we need to do to address the problem.

By Terri Wilder, M.S.W.
cisgender woman prescription

Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It

Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.

By Terri Wilder, M.S.W.
Peter Staley Brenda Emily Goodrow and Mark Lemley credit Ivy Arce

Oral Arguments in Antitrust Case Against HIV Drug Companies Began Last Week. Plaintiff Peter Staley Explains the Case

The case could change the way pharma companies make agreements to keep generic versions of single-tablet pills at bay.

By Terri Wilder, M.S.W.
Johanne Morne and Dr. Oni Blackstock

Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work

Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.

By Terri Wilder, M.S.W.
Christina Garcia and Patricia "PJ" Nachman of TIN Rx

To Combat LGBTQ and HIV Stigma, These Two Women Are Reinventing the Pharmacy

For people taking medications for HIV prevention, HIV treatment, STIs, or transgender health care, this couple -- in life and in business -- seeks to revolutionize the pharmacy experience at TIN Rx in San Francisco.

By Terri Wilder, M.S.W.
Samuel J. Bunting

Getting PrEP to People by Training Entire Health Teams

Primary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.

By Terri Wilder, M.S.W.